In-vivo antidiabetic activity of asparagus racemosus seeds in streptozotocin induced diabetic model

https://doi.org/10.55522/ijti.V2I3.0037

Abstract

The point of this study was to find out how well the methanolic seed extract of Asparagus racemosus treated diabetes in rats that had been given streptozotocin (STZ). We administered a single intraperitoneal injection of STZ (65 mg/kg) to the experimental animal to achieve the desired effect. We divided a group of adult male Wister albino rats into five groups: normal control, diabetic control, diabetic glibenclamide (5 mg/kg), diabetic methanolic seed extract of Asparagus racemosus (200 mg/kg), and diabetic methanolic seed extract of Asparagus racemosus extract (400 mg/kg).